6 Patents
- US123970292025Use of MVA or MVADELTAE3L as Immunotherapeutic Agents Against Solid Tumors
MEMORIAL SLOAN KETTERING CANCER CENTER
0 cites - 0 cites
- US120362792024Recombinant MVA or MVADELE3L Expressing Human FLT3L and Use Thereof as Immuno-therapeutic Agents Against Solid Tumors
Memorial Sloan Kettering Cancer Center
0 cites - US119865032024Replication Competent Attenuated Vaccinia Viruses with Deletion of Thymidine Kinase with and Without the Expression of Human Flt3l or GM-CSF for Cancer Immunotherapy
Memorial Sloan Kettering Cancer Center
0 cites - US118849392024Vaccinia Virus Mutants Useful for Cancer Immunotherapy
Memorial Sloan Kettering Cancer Center
0 cites - US115410872023Replication Competent Attenuated Vaccinia Viruses with Deletion of Thymidine Kinase with and Without the Expression of Human Flt3l or GM-CSF for Cancer Immunotherapy
MEMORIAL SLOAN KETTERING CANCER CENTER
0 cites